We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Revolutionary Bio-Hydrogel Implant Coating Could Reduce Risk of Device Rejection

By HospiMedica International staff writers
Posted on 27 Jul 2023

The ongoing fight against infections and microbial resistance continues to pose significant challenges in healthcare. Implant-associated infections, for instance, heighten the risk of device rejection, thereby endangering patient health and adding to the increasing problem of antimicrobial resistance. Conventional treatments, including lengthy antibiotic courses, often fall short against such resilient bacterial communities, further complicating the problem. Now, a new initiative is taking a bold and innovative approach to address this issue by shifting from the conventional method of directly combating pathogenic bacteria to instead harness them as beneficial allies in enhancing tissue regeneration for improved implant integration. This groundbreaking perspective could bring about a paradigm shift in managing infections.

The Bioaction (Europe) project, a collaboration involving four research centers, two universities, and two companies from five European countries, is set to develop functional bio-hydrogels. These hydrogels are designed to trigger local remodeling of physiological processes to expedite healing and stimulate bone growth. They will be designed as injectable materials or implant coatings for minimally invasive applications. Over the next four years, the project's researchers will validate this technology using clinically relevant models for dental implants and permanent transcutaneous prostheses. However, the transformative influence of Bioaction reaches beyond these specific applications. By reducing dependence on extended antibiotic treatments and minimizing failure rates, this trailblazing project has the potential to revolutionize methods of treating infections. Ultimately, Bioaction aims to enhance patient quality of life while making a significant contribution to the global fight against antimicrobial resistance.

“The Bioaction project proposes a visionary approach that will be pursued thanks to real interdisciplinarity,” said Luigi Ambrosio, project coordinator. “Our partners’ diverse expertise and skills in synthetic biology, biomaterials, microbiology, and beyond will surely be the basis for the project’s success.”

Related Links:
Bioaction

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Infant Incubator
OKM 801
Infrared Digital Thermometer
R1B1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.